We are live on ! Find out more
HARP

Harpoon Therapeutics, Inc. Common Stock
HARP

Delisted

HARP was delisted on the 8th of March, 2024.

Back to rankings

79 hedge funds and large institutions have $128M invested in Harpoon Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more call options, than puts

Call options by funds: $193K | Put options by funds: $185K

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less funds holding

Funds holding: 84 → 79 (-5)

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

26% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 19

35% less capital invested

Capital invested by funds: $196M → $128M (-$68.1M)

Holders
79
Holders Change
-5
Holders Change %
-5.95%
% of All Funds
1.25%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
21
Reduced
25
Closed
19
Calls
$193K
Puts
$185K
Net Calls
+$8K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.69M
2
ACP
Acuta Capital Partners
California
+$2.58M
3
Franklin Resources
Franklin Resources
California
+$2.34M
4
TCM
Tekla Capital Management
Massachusetts
+$1.35M
5
Renaissance Technologies
Renaissance Technologies
New York
+$827K

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$14.6M
2
NCM
Nantahala Capital Management
Connecticut
-$3.59M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.78M
4
Two Sigma Investments
Two Sigma Investments
New York
-$887K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$677K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$518K -$677K -13,060 -56%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$513K +$179K +3,458 +50%
State of Wisconsin Investment Board
28
State of Wisconsin Investment Board
Wisconsin
$509K +$531K +10,240 New
BCM
29
Bridgeway Capital Management
Texas
$478K +$499K +9,626 New
Federated Hermes
30
Federated Hermes
Pennsylvania
$455K -$188K -3,622 -28%
PAM
31
Panagora Asset Management
Massachusetts
$347K -$79.4K -1,532 -18%
Fidelity Investments
32
Fidelity Investments
Massachusetts
$332K +$346K +6,680 New
Charles Schwab
33
Charles Schwab
California
$267K +$19.3K +372 +7%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$245K +$1.76K +34 +0.7%
N
35
Nuveen
North Carolina
$231K – – –
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$140K +$23.3K +450 +19%
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$128K +$57.3K +1,105 +75%
SO
38
STRS Ohio
Ohio
$127K – – –
AQR Capital Management
39
AQR Capital Management
Connecticut
$126K -$21.6K -416 -14%
AllianceBernstein
40
AllianceBernstein
Tennessee
$115K – – –
Morgan Stanley
41
Morgan Stanley
New York
$94K +$31.7K +612 +48%
CSS
42
Cubist Systematic Strategies
Connecticut
$92K +$92K +1,775 +2,219%
Millennium Management
43
Millennium Management
New York
$89K -$435K -8,391 -82%
Barclays
44
Barclays
United Kingdom
$88K -$102K -1,966 -53%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$86K +$11.8K +228 +15%
CC
46
Corton Capital
Ontario, Canada
$83K +$86.7K +1,672 New
Connor, Clark & Lunn Investment Management (CC&L)
47
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$74K -$45.2K -873 -37%
SFA
48
Sequoia Financial Advisors
Ohio
$66K +$68.4K +1,320 New
DU
49
Delphia (USA)
Ontario, Canada
$57K +$59.7K +1,151 New
BFM
50
Boothbay Fund Management
New York
$56K – – –
1
2
3 4

HARP Hedge Fund Activity: Q1 2022 in Review

79 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Harpoon Therapeutics, Inc. Common Stock (HARP) for Q1 2022, worth a combined $128M — down 35% from $196M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of HARP and 14 opened new positions — a net loss of 5 holders — while 25 trimmed existing stakes and 21 added.

The largest buyer was Point72 Asset Management, adding an estimated $2.69M. The largest seller was Logos Global Management, exiting entirely with an estimated $14.6M sold.

  • 79 institutional investors held Harpoon Therapeutics, Inc. Common Stock (HARP) as of Q1 2022, down from 84 in Q4 2021.
  • Funds reported $128M of Harpoon Therapeutics, Inc. Common Stock stock for Q1 2022, down 35% quarter-over-quarter.
  • 14 funds opened new Harpoon Therapeutics, Inc. Common Stock positions in Q1 2022 and 19 closed out, a net change of -5 holders.
  • The largest Harpoon Therapeutics, Inc. Common Stock buyer in Q1 2022 was Point72 Asset Management, an estimated $2.69M added.
  • The largest Harpoon Therapeutics, Inc. Common Stock seller in Q1 2022 was Logos Global Management, an estimated $14.6M sold.

Based on aggregated 13F filings for Q1 2022.